首页
订购/客服:400-666-5481

MLN8054

    
98.80%

MLN8054

源叶(MedMol)
S81036 一键复制产品信息
869363-13-3
C25H15ClF2N4O2
476.86
4-[[9-氯-7-(2,6-二氟苯基)-5H-嘧啶并[5,4-D][2]苯并氮杂卓-2-基]氨基]苯甲酸;Benzoic acid, 4-[[9-chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S81036-5mg买3赠1
98.80%

¥712.00

5 - - - -
S81036-10mg买3赠1
98.80%

¥1200.00

7 - - - -
S81036-50mg买3赠1
98.80%

¥3600.00

3 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: MLN8054 is a potent, selective and orally available aurora A kinase inhibitor with an IC50 of 4 nM.
靶点: Aurora A:4 nM (IC50);CaseinKinase; PKA; Src; AuroraKinase
体内研究: In the HCT-116 tumor-bearing mice, MLN8054 treatment inhibits tumor growth dose dependently. MLN8054 is generally well tolerated. MLN8054 also inhibits the growth of the PC-3 tumor xenograft in nude mice. MLN8054 Treatment Results in Inhibition of Aurora A, Accumulation of Mitotic Cells, and Apoptosis in vivo. MLN8054 selectively inhibits Aurora A kinase activity when dosed at 30 mg/kg. At this dose in HCT116 tumor tissue, MLN8054 has been shown to inhibit Aurora A autophosphorylation, and induce an increase in the Aurora B substrate, pHisH3
参考文献: 1. Manfredi MG, et al. Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase. Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4106-11. 2. Huck JJ, et al. MLN8054, an inhibitor of Aurora A kinase, induces senescence in human tumor cells both in vitro and in vivo. Mol Cancer Res. 2010 Mar;8(3):373-84.
溶解性: DMSO  :  20.83  mg/mL  (43.68  mM;  ultrasonic  and  warming  and  heat  to  60°C)
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.097 ml 10.485 ml 20.971 ml
5 mM 0.419 ml 2.097 ml 4.194 ml
10 mM 0.21 ml 1.049 ml 2.097 ml
50 mM 0.042 ml 0.21 ml 0.419 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×